1 completed, 1 unknown, 1 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
Follow Cardiac Arrhythmia: new trials by email Literature Review of Cardiac Arrhythmia trials Research Report on Cardiac Arrhythmia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT) HSK3486, Moxifloxacin Hydrochloride, Placebo - Anesthesia; Adverse Effect, Cardiac Arrhythmia | Phase 1 | Completed | Haisco-USA Pharmaceuticals, Inc. | 48 | 2024-04-09 | 2026-01-13 |
| SBRT in Chagas Disease Ventricular Tachycardia Stereotactic Body Radiation Therapy - Ventricular Tachycardia, Chagas Disease | Phase 1 / Phase 2 | Unknown | University of Sao Paulo General Hospital | 10 | 2021-07-14 | 2024-07-16 |
| Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART) stereotactic ablative radiotherapy (SABR), Standard of Treatment - Cardiac Arrhythmia, Cardiac | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2019-09-12 | 2024-02-13 |
Arrhythmias, Cardiac (3) · Tachycardia, Ventricular (2) · Chagas Disease (1)
Cardiovascular Diseases (3) · Heart Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Cardiac Conduction System Disease (2) · Tachycardia (2) · Euglenozoa Infections (1) · Infections (1) · Parasitic Diseases (1) · Protozoan Infections (1) · Trypanosomiasis (1) · Vector Borne Diseases (1)
HSK3486 (1) · Moxifloxacin (1) · Radiosurgery (1)
Haisco-USA Pharmaceuticals, Inc. (1) · M.D. Anderson Cancer Center (1) · University of Sao Paulo General Hospital (1)
Brazil (1) · China (1)
Joe Chang, MD (1) · Mauricio I Scanavacca, MD, PhD (1)